Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease (Q44737007)

5 December 2017

title

Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease (English)

1 reference

5 December 2017

1 reference

1 reference

1 reference

1 reference

Wassilios G. Meissner

2

1 reference

5 December 2017

Gesine Paul

1

1 reference

5 December 2017

Susanne Rein

3

1 reference

5 December 2017

Daniel Harnack

4

1 reference

5 December 2017

Christine Winter

5

1 reference

5 December 2017

Kai Hosmann

6

1 reference

5 December 2017

Rudolf Morgenstern

7

1 reference

5 December 2017

Andreas Kupsch

8

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

5 December 2017

published in

Experimental Neurology

1 reference

5 December 2017

volume

185

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

272-280

1 reference

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Intracerebral neural implants: neuronal replacement and reconstruction of damaged circuitries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Subthalamic ablation reverses changes in basal ganglia oxidative metabolism and motor response to apomorphine induced by nigrostriatal lesion in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Blockade of subthalamic glutamatergic activity corrects changes in neuronal metabolism and motor behavior in rats with nigrostriatal lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Primate models of movement disorders of basal ganglia origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

The Effects of Activation or Inhibition of the Subthalamic Nucleus on the Metabolic and Electrophysiological Activities Within the Pallidal Complex and Substantia Nigra in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Glutamate and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Electrophysiological demonstration of an excitatory subthalamonigral pathway in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Behavioural effects of subthalamic nucleus lesions in the hemiparkinsonian marmoset (Callithrix jacchus).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Subthalamic nucleus lesions induce deficits as well as benefits in the hemiparkinsonian rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: an in situ hybridization study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Subthalamic GAD gene therapy in a Parkinson's disease rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Excitatory amino acid neurotoxicity and neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

The role of the subthalamic nucleus in the response of globus pallidus neurons to stimulation of the prelimbic and agranular frontal cortices in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Fluoro-Gold: a new fluorescent retrograde axonal tracer with numerous unique properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900363-7

10.1016/S0014-4886(03)00363-7

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference